logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

HIV-associated Kaposi's sarcoma in Maputo, Mozambique: outcomes in a specialized treatment center, 2010-2015

Fardhdiani V, Molfino L, Zamudio AG, Manuel R, Luciano G,  et al.
2018-01-19 • Infectious Agents and Cancer
2018-01-19 • Infectious Agents and Cancer
Kaposi's sarcoma (KS) is a common HIV-associated malignancy associated with disability, pain and poor outcomes. The cornerstone of its treatment is antiretroviral therapy, but advanced d...
Journal Article
|
Research

Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin

Coldiron ME, Gutierrez Zamudio AG, Manuel R, Luciano G, Rusch B,  et al.
2021-01-07 • Infectious Agents and Cancer
2021-01-07 • Infectious Agents and Cancer
BACKGROUND
Kaposi’s sarcoma (KS) is a common HIV-associated malignancy frequently associated with poor outcomes. It is the most frequently diagnosed cancer in major cities of Mozambi...
Journal Article
|
Research

I saw it as a second chance- a qualitative exploration of experiences of treatment failure and regimen change among people living with HIV on second- and third-line antiretroviral therapy in Kenya, Malawi and Mozambique

Burns R, Borges J, Blasco P, Vandenbulcke A, Mukui I,  et al.
2019-01-11 • Global Public Health
2019-01-11 • Global Public Health
Increasing numbers of people living with HIV (PLHIV) in sub-Saharan Africa are experiencing failure of first-line antiretroviral therapy and transitioning onto second-line regimens. Howe...